Satellos BioscienceMSLE
13F holders, Q2 2026 (June 30)At the end of Q2 2026, 26 institutions reported holding Satellos Bioscience Inc. (MSLE) in their 13F filings, down 5 from Q1 2026. 2 opened new positions and 7 sold out. The largest holders were Franklin Resources Inc. ($7.2M), Siren, L.L.C. ($6.9M) and Vivo Capital, LLC ($6.3M). 3 famous investors held it, including Steve Cohen (0.0% of Point72 Asset Management's portfolio), Israel Englander (0.0% of Millennium Management's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Satellos Bioscience Inc.
- CUSIP
- 80401L803
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $1.4M |
| Exits | 7 | $475K |
All 13F filers, Q1 2026 → Q2 2026: 779,470 shares bought and 692,044 shares sold, net +87,426 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 26 holders
| Franklin Resources Inc. | 0.00% | No change | 938,666 | $7.2M |
| Siren, L.L.C. | 0.14% | No change | 892,074 | $6.9M |
| Vivo Capital, LLC | 0.58% | No change | 813,666 | $6.3M |
| Point72 Asset Management | 0.01% | Reduce -1.2% | 682,700 | $5.3M |
| Sphera Funds Management LTD. | 0.73% | Add +33.4% | 652,590 | $5.1M |
| Woodline Partners LP | 0.01% | No change | 500,432 | $3.9M |
| Stonepine Capital Management, LLC | 2.83% | Add +391.6% | 491,624 | $3.7M |
| Montanova Capital, LLC | 0.08% | No change | 475,000 | $3.7M |
| Avidity Partners Management LP | 0.48% | No change | 387,769 | $3.0M |
| Saturn V Capital Management LP | 0.39% | No change | 350,000 | $2.7M |
| Soleus Capital Management, L.P. | 0.08% | Reduce -24.1% | 314,359 | $2.4M |
| 683 Capital Management, LLC | 0.17% | No change | 230,833 | $1.8M |
| ADAR1 Capital Management, LLC | 0.08% | No change | 222,555 | $1.7M |
| AWM Investment Company, Inc. | 0.12% | New | 180,000 | $1.4M |
| Millennium Management | 0.00% | Reduce -48.8% | 152,768 | $1.2M |
| Adage Capital Partners Gp, L.L.C. | 0.00% | Reduce -60.6% | 150,000 | $1.2M |
| Empery Asset Management, LP | 0.98% | Reduce -53.5% | 107,100 | $833K |
| Citadel Advisors | 0.00% | Add +59.4% | 67,738 | $527K |
| Morgan Stanley | 0.00% | Add +21.5% | 25,732 | $200K |
| China Universal Asset Management Co., Ltd. | 0.01% | Add +212.5% | 20,000 | $156K |
| Royal Bank of Canada | 0.00% | Reduce -2.4% | 15,863 | $124K |
| Geode Capital Management, LLC | 0.00% | No change | 11,907 | $93K |
| UBS Group AG | 0.00% | Add +2689.3% | 781 | $6K |
| JPMorgan Chase & Co. | 0.00% | New | 315 | $2K |
| Federation des caisses Desjardins du Quebec | 0.00% | No change | 19 | $143 |
| Caitong International Asset Management Co., Ltd | 0.00% | No change | 1 | $8 |
"% of holder's portfolio" is MSLE's weight in each manager's 13F, not the share of Satellos Bioscience Inc. the manager owns.